{
    "abstract": "In 2015, outbreaks of foot-and-mouth disease (FMD) in the Middle East were discovered to be caused by a viral lineage (A/ASIA/G-VII), which has recently emerged from the Indian sub-continent. In vitro vaccine matching data generated by the World Reference Laboratory (WRLFMD) indicated that A/ASIA/G-VII field viruses were poorly matched with vaccines (A-SAU-95, A22 IRQ and A-IRN-05) that are already used in the region. In order to assess the likely performance of one of these commercially available FMD vaccines, sixteen cattle were vaccinated with a polyvalent vaccine which contained two serotype A components (A-SAU-95 and A-IRN-05) with a homologous potency of at least 6PD50, and two cattle were left unvaccinated as controls. Twenty-one days later, all 18 cattle were challenged by tongue inoculation with an FMDV field isolate A/IRN/22/2015 from the A/ASIA/G-VII lineage, in line with the European Pharmacopeia PPG test conditions. The two control animals developed generalised FMD, and 7/16 vaccinated animals developed at least one foot lesion, thus only 56.3% were defined as protected. For the vaccine components, there was a significant increase in the probability of protection with increasing serological titres for A-SAU-95 (p = 0.03), but not for A-IRN-05 (p = 0.42). Analysis of FMDV in blood and nasal swabs suggested that vaccination reduced shedding and potential onward spread of FMD virus even if the animal developed foot lesions. In summary, the results from this study suggest that whilst this vaccine would not be appropriate for use in an emergency situation (in previously FMD-free countries), it may be partially effective in the field in endemic countries where repeat prophylactic vaccination is practiced. For emergency reactive vaccination, the findings from this study support the idea that a new vaccine strain should be developed that is tailored to the A/ASIA/G-VII lineage.",
    "author_highlights": [
        {
            "endOffset": 13676,
            "sentence": "FMDV A/ASIA/G-VII lineage has recently spread beyond the Indian sub-continent.",
            "startOffset": 13598
        },
        {
            "endOffset": 13756,
            "sentence": "Study evaluated the performance of a high potency polyvalent vaccine in cattle.",
            "startOffset": 13677
        },
        {
            "endOffset": 13844,
            "sentence": "A new vaccine strain should be developed which is tailored to the A/ASIA/G-VII lineage.",
            "startOffset": 13757
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "A. P.",
                    "initial": "A.P.",
                    "last": "Power"
                },
                {
                    "first": "S. A.",
                    "initial": "S.A.",
                    "last": "Harris"
                }
            ],
            "doi": "10.1111/j.1477-9552.1973.tb00955.x",
            "firstpage": "573",
            "issn": "0021857X",
            "lastpage": "600",
            "pub_year": 1973,
            "title": "A COST\u2010BENEFIT EVALUATION OF ALTERNATIVE CONTROL POLICIES FOR FOOT\u2010AND\u2010MOUTH DISEASE IN GREAT BRITAIN",
            "volume": "24"
        },
        "b0010": {
            "authors": [
                {
                    "first": "M. M.",
                    "initial": "M.M.",
                    "last": "Rweyemamu"
                },
                {
                    "first": "Y.",
                    "initial": "Y.",
                    "last": "Leforban"
                }
            ],
            "firstpage": "111",
            "issn": "00653527",
            "lastpage": "126",
            "pmid": "10582097",
            "pub_year": 1999,
            "title": "Foot-and-mouth disease and international development.",
            "volume": "53"
        },
        "b0015": {
            "authors": [
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Paton"
                },
                {
                    "first": "Keith J.",
                    "initial": "K.J.",
                    "last": "Sumption"
                },
                {
                    "first": "Bryan",
                    "initial": "B.",
                    "last": "Charleston"
                }
            ],
            "doi": "10.1098/rstb.2009.0100",
            "firstpage": "2657",
            "issn": "09628436",
            "lastpage": "2667",
            "pmid": "19687036",
            "pub_year": 2009,
            "title": "Options for control of foot-and-mouth disease: Knowledge, capability and policy",
            "volume": "364"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Hans G.",
                    "initial": "H.G.",
                    "last": "Bahnemann"
                }
            ],
            "doi": "10.1016/0264-410X(90)90083-X",
            "firstpage": "299",
            "issn": "0264410X",
            "lastpage": "303",
            "pmid": "2204242",
            "pub_year": 1990,
            "title": "Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethylenimine",
            "volume": "8"
        },
        "b0025": null,
        "b0030": {
            "authors": [
                {
                    "first": "D. J.",
                    "initial": "D.J.",
                    "last": "Paton"
                },
                {
                    "first": "J. F.",
                    "initial": "J.F.",
                    "last": "Valarcher"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Bergmann"
                },
                {
                    "first": "O. G.",
                    "initial": "O.G.",
                    "last": "Matlho"
                },
                {
                    "first": "V. M.",
                    "initial": "V.M.",
                    "last": "Zakharov"
                },
                {
                    "first": "E. L.",
                    "initial": "E.L.",
                    "last": "Palma"
                },
                {
                    "first": "G. R.",
                    "initial": "G.R.",
                    "last": "Thomson"
                }
            ],
            "doi": "10.20506/rst.24.3.1632",
            "firstpage": "981",
            "issn": "02531933",
            "lastpage": "993",
            "pmid": "16642769",
            "pub_year": 2005,
            "title": "Selection of foot and mouth disease vaccine strains - A review",
            "volume": "24"
        },
        "b0035": {
            "authors": [
                {
                    "first": "N. P.",
                    "initial": "N.P.",
                    "last": "Ferris"
                },
                {
                    "first": "A. I.",
                    "initial": "A.I.",
                    "last": "Donaldson"
                }
            ],
            "doi": "10.20506/rst.11.3.626",
            "firstpage": "657",
            "issn": "02531933",
            "lastpage": "684",
            "pmid": "1335302",
            "pub_year": 1992,
            "title": "The World Reference Laboratory for Foot and Mouth Disease: a review of thirty-three years of activity (1958-1991).",
            "volume": "11"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Mark M.",
                    "initial": "M.M.",
                    "last": "Rweyemamu"
                }
            ],
            "doi": "10.1016/S0092-1157(84)80013-X",
            "firstpage": "323",
            "issn": "00921157",
            "lastpage": "337",
            "pmid": "6207176",
            "pub_year": 1984,
            "title": "Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction",
            "volume": "13"
        },
        "b0045": {
            "authors": [
                {
                    "first": "K. E.",
                    "initial": "K.E.",
                    "last": "Brehm"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Kumar"
                },
                {
                    "first": "H. H.",
                    "initial": "H.H.",
                    "last": "Thulke"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Haas"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.01.038",
            "firstpage": "1681",
            "issn": "0264410X",
            "lastpage": "1687",
            "pmid": "18313814",
            "pub_year": 2008,
            "title": "High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus",
            "volume": "26"
        },
        "b0050": null,
        "b0055": null,
        "b0060": null,
        "b0065": {
            "authors": [
                {
                    "first": "Nicholas A.",
                    "initial": "N.A.",
                    "last": "Lyons"
                },
                {
                    "first": "Anna B.",
                    "initial": "A.B.",
                    "last": "Ludi"
                },
                {
                    "first": "Ginette",
                    "initial": "G.",
                    "last": "Wilsden"
                },
                {
                    "first": "Pip",
                    "initial": "P.",
                    "last": "Hamblin"
                },
                {
                    "first": "Ibrahim Ahmed",
                    "initial": "I.A.",
                    "last": "Qasim"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Gubbins"
                },
                {
                    "first": "Donald P.",
                    "initial": "D.P.",
                    "last": "King"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.10.029",
            "firstpage": "6850",
            "issn": "0264410X",
            "lastpage": "6857",
            "pmid": "29108665",
            "pub_year": 2017,
            "title": "Evaluation of a polyvalent foot-and-mouth disease virus vaccine containing A Saudi-95 against field challenge on large-scale dairy farms in Saudi Arabia with the emerging A/ASIA/G-VII viral lineage",
            "volume": "35"
        },
        "b0070": {
            "authors": [
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "Bachanek-Bankowska"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Wadsworth"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Thapa"
                },
                {
                    "first": "D. P.",
                    "initial": "D.P.",
                    "last": "King"
                },
                {
                    "first": "N. J.",
                    "initial": "N.J.",
                    "last": "Knowles"
                }
            ],
            "doi": "10.1128/genomeA.01591-15",
            "issn": "21698287",
            "pub_year": 2016,
            "title": "Complete genome sequence of a serotype A foot-and-mouth disease virus from an outbreak in Saudi Arabia during 2015",
            "volume": "4"
        },
        "b0075": null,
        "b0080": {
            "authors": [
                {
                    "first": "W. A.",
                    "initial": "W.A.",
                    "last": "Snowdon"
                }
            ],
            "doi": "10.1038/2101079a0",
            "firstpage": "1079",
            "issn": "00280836",
            "lastpage": "1080",
            "pmid": "4288087",
            "pub_year": 1966,
            "title": "Growth of foot-and-mouth disease virus in monolayer cultures of calf thyroid cells [49]",
            "volume": "210"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Carol",
                    "initial": "C.",
                    "last": "House"
                },
                {
                    "first": "James A.",
                    "initial": "J.A.",
                    "last": "House"
                }
            ],
            "doi": "10.1016/0378-1135(89)90033-3",
            "firstpage": "99",
            "issn": "03781135",
            "lastpage": "109",
            "pmid": "2549683",
            "pub_year": 1989,
            "title": "Evaluation of techniques to demonstrate foot-and-mouth disease virus in bovine tongue epithelium: Comparison of the sensitivity of cattle, mice, primary cell cultures, cryopreserved cell cultures and established cell lines",
            "volume": "20"
        },
        "b0090": {
            "authors": [
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Goris"
                },
                {
                    "first": "P.",
                    "initial": "P.",
                    "last": "Merkelbach-Peters"
                },
                {
                    "first": "V. I.",
                    "initial": "V.I.",
                    "last": "Diev"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Verloo"
                },
                {
                    "first": "V. M.",
                    "initial": "V.M.",
                    "last": "Zakharov"
                },
                {
                    "first": "H. P.",
                    "initial": "H.P.",
                    "last": "Kraft"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "De Clercq"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.12.049",
            "firstpage": "3373",
            "issn": "0264410X",
            "lastpage": "3379",
            "pmid": "17227691",
            "pub_year": 2007,
            "title": "European Pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: Between test variability and its consequences",
            "volume": "25"
        },
        "b0095": {
            "authors": [
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Goris"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Maradei"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "D'Aloia"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Fondevila"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Mattion"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Perez"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Smitsaart"
                },
                {
                    "first": "H. J.",
                    "initial": "H.J.",
                    "last": "Nauwynck"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "La Torre"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Palma"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "De Clercq"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.04.034",
            "firstpage": "3432",
            "issn": "0264410X",
            "lastpage": "3437",
            "pmid": "18499310",
            "pub_year": 2008,
            "title": "Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: Precision of the \"Protection against Podal Generalisation\" test",
            "volume": "26"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Emma",
                    "initial": "E.",
                    "last": "Fishbourne"
                },
                {
                    "first": "Anna B.",
                    "initial": "A.B.",
                    "last": "Ludi"
                },
                {
                    "first": "Ginette",
                    "initial": "G.",
                    "last": "Wilsden"
                },
                {
                    "first": "Pip",
                    "initial": "P.",
                    "last": "Hamblin"
                },
                {
                    "first": "Bob",
                    "initial": "B.",
                    "last": "Statham"
                },
                {
                    "first": "Abdelghani",
                    "initial": "A.",
                    "last": "Bin-Tarif"
                },
                {
                    "first": "Emiliana",
                    "initial": "E.",
                    "last": "Brocchi"
                },
                {
                    "first": "Santina",
                    "initial": "S.",
                    "last": "Grazioli"
                },
                {
                    "first": "Aldo",
                    "initial": "A.",
                    "last": "Dekker"
                },
                {
                    "first": "Phaedra",
                    "initial": "P.",
                    "last": "Ebl\u00e9"
                },
                {
                    "first": "Donald P.",
                    "initial": "D.P.",
                    "last": "King"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.02.047",
            "firstpage": "2761",
            "issn": "0264410X",
            "lastpage": "2765",
            "pmid": "28396208",
            "pub_year": 2017,
            "title": "Efficacy of a high potency O1 Manisa foot-and-mouth disease vaccine in cattle against heterologous challenge with a field virus from the O/ME-SA/Ind-2001 lineage collected in North Africa",
            "volume": "35"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Johnny D.",
                    "initial": "J.D.",
                    "last": "Callahan"
                },
                {
                    "first": "Fred",
                    "initial": "F.",
                    "last": "Brown"
                },
                {
                    "first": "Fernando A.",
                    "initial": "F.A.",
                    "last": "Osorio"
                },
                {
                    "first": "Jung H.",
                    "initial": "J.H.",
                    "last": "Sur"
                },
                {
                    "first": "Ed",
                    "initial": "E.",
                    "last": "Kramer"
                },
                {
                    "first": "Gary W.",
                    "initial": "G.W.",
                    "last": "Long"
                },
                {
                    "first": "Juan",
                    "initial": "J.",
                    "last": "Lubroth"
                },
                {
                    "first": "Stefanie J.",
                    "initial": "S.J.",
                    "last": "Ellis"
                },
                {
                    "first": "Katina S.",
                    "initial": "K.S.",
                    "last": "Shoulars"
                },
                {
                    "first": "Kristin L.",
                    "initial": "K.L.",
                    "last": "Gaffney"
                },
                {
                    "first": "Daniel L.",
                    "initial": "D.L.",
                    "last": "Rock"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Nelson"
                }
            ],
            "doi": "10.2460/javma.2002.220.1636",
            "firstpage": "1636",
            "issn": "00031488",
            "lastpage": "1642",
            "pmid": "12051502",
            "pub_year": 2002,
            "title": "Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus",
            "volume": "220"
        },
        "b0110": {
            "authors": [
                {
                    "first": "K. E.",
                    "initial": "K.E.",
                    "last": "Brehm"
                },
                {
                    "first": "N. P.",
                    "initial": "N.P.",
                    "last": "Ferris"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Lenk"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "Riebe"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Haas"
                }
            ],
            "doi": "10.1128/JCM.00510-09",
            "firstpage": "3156",
            "issn": "00951137",
            "lastpage": "3160",
            "pmid": "19656987",
            "pub_year": 2009,
            "title": "Highly sensitive fetal goat tongue cell line for detection and isolation of foot-and-mouth disease virus",
            "volume": "47"
        },
        "b0115": {
            "authors": [
                {
                    "first": "I. Martin",
                    "initial": "I.M.",
                    "last": "Sheldon"
                },
                {
                    "first": "Erin J.",
                    "initial": "E.J.",
                    "last": "Williams"
                },
                {
                    "first": "Aleisha N.A.",
                    "initial": "A.N.A.",
                    "last": "Miller"
                },
                {
                    "first": "Deborah M.",
                    "initial": "D.M.",
                    "last": "Nash"
                },
                {
                    "first": "Shan",
                    "initial": "S.",
                    "last": "Herath"
                }
            ],
            "doi": "10.1016/j.tvjl.2007.12.031",
            "firstpage": "115",
            "issn": "10900233",
            "lastpage": "121",
            "pmid": "18329302",
            "pub_year": 2008,
            "title": "Uterine diseases in cattle after parturition",
            "volume": "176"
        },
        "b0120": {
            "authors": [
                {
                    "first": "Jacquelyn",
                    "initial": "J.",
                    "last": "Horsington"
                },
                {
                    "first": "Zhidong",
                    "initial": "Z.",
                    "last": "Zhang"
                },
                {
                    "first": "Hilary",
                    "initial": "H.",
                    "last": "Bittner"
                },
                {
                    "first": "Kate",
                    "initial": "K.",
                    "last": "Hole"
                },
                {
                    "first": "Nagendrakumar B.",
                    "initial": "N.B.",
                    "last": "Singanallur"
                },
                {
                    "first": "Soren",
                    "initial": "S.",
                    "last": "Alexandersen"
                },
                {
                    "first": "Wilna",
                    "initial": "W.",
                    "last": "Vosloo"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.11.043",
            "firstpage": "422",
            "issn": "0264410X",
            "lastpage": "429",
            "pmid": "25483241",
            "pub_year": 2015,
            "title": "Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine",
            "volume": "33"
        },
        "b0125": {
            "authors": [
                {
                    "first": "E. A.",
                    "initial": "E.A.",
                    "last": "Le\u00f3n"
                },
                {
                    "first": "A. M.",
                    "initial": "A.M.",
                    "last": "Perez"
                },
                {
                    "first": "M. A.",
                    "initial": "M.A.",
                    "last": "Stevenson"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Robiolo"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Mattion"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Seki"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "La Torres"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Torre"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Cosentino"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Duffy"
                }
            ],
            "doi": "10.20506/rst.33.3.2329",
            "firstpage": "917",
            "issn": "02531933",
            "lastpage": "926",
            "pmid": "25812215",
            "pub_year": 2014,
            "title": "Effectiveness of systematic foot and mouth disease mass vaccination campaigns in Argentina",
            "volume": "33"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Y. L.Vianna",
                    "initial": "Y.L.V.",
                    "last": "Filho"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Astudillo"
                },
                {
                    "first": "I.",
                    "initial": "I.",
                    "last": "Gomes"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Fern\u00e1ndez"
                },
                {
                    "first": "C. E.E.",
                    "initial": "C.E.E.",
                    "last": "Rozas"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Ravison"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Alonso"
                }
            ],
            "doi": "10.1016/0264-410X(93)90171-S",
            "firstpage": "1424",
            "issn": "0264410X",
            "lastpage": "1428",
            "pmid": "8310761",
            "pub_year": 1993,
            "title": "Potency control of foot-and-mouth disease vaccine in cattle. Comparison of the 50% protective dose and the protection against generalization",
            "volume": "11"
        },
        "b0135": null,
        "b0140": {
            "authors": [
                {
                    "first": "Paul V.",
                    "initial": "P.V.",
                    "last": "Barnett"
                },
                {
                    "first": "Robert J.",
                    "initial": "R.J.",
                    "last": "Statham"
                },
                {
                    "first": "Wilna",
                    "initial": "W.",
                    "last": "Vosloo"
                },
                {
                    "first": "Daniel T.",
                    "initial": "D.T.",
                    "last": "Haydon"
                }
            ],
            "doi": "10.1016/S0264-410X(03)00219-6",
            "firstpage": "3240",
            "issn": "0264410X",
            "lastpage": "3248",
            "pmid": "12804854",
            "pub_year": 2003,
            "title": "Foot-and-mouth disease vaccine potency testing: Determination and statistical validation of a model using a serological approach",
            "volume": "21"
        },
        "b0145": {
            "authors": [
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Cox"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Voyce"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Parida"
                },
                {
                    "first": "S. M.",
                    "initial": "S.M.",
                    "last": "Reid"
                },
                {
                    "first": "P. A.",
                    "initial": "P.A.",
                    "last": "Hamblin"
                },
                {
                    "first": "D. J.",
                    "initial": "D.J.",
                    "last": "Paton"
                },
                {
                    "first": "P. V.",
                    "initial": "P.V.",
                    "last": "Barnett"
                }
            ],
            "doi": "10.1016/j.vaccine.2004.08.034",
            "firstpage": "1106",
            "issn": "0264410X",
            "lastpage": "1113",
            "pmid": "15629353",
            "pub_year": 2005,
            "title": "Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx",
            "volume": "23"
        },
        "b0150": {
            "authors": [
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Cox"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Voyce"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Parida"
                },
                {
                    "first": "S. M.",
                    "initial": "S.M.",
                    "last": "Reid"
                },
                {
                    "first": "P. A.",
                    "initial": "P.A.",
                    "last": "Hamblin"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Hutchings"
                },
                {
                    "first": "D. J.",
                    "initial": "D.J.",
                    "last": "Paton"
                },
                {
                    "first": "P. V.",
                    "initial": "P.V.",
                    "last": "Barnett"
                }
            ],
            "doi": "10.1016/j.vaccine.2006.01.037",
            "firstpage": "3184",
            "issn": "0264410X",
            "lastpage": "3190",
            "pmid": "16488060",
            "pub_year": 2006,
            "title": "Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle",
            "volume": "24"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Bryan",
                    "initial": "B.",
                    "last": "Charleston"
                },
                {
                    "first": "Bartlomies M.",
                    "initial": "B.M.",
                    "last": "Bankowski"
                },
                {
                    "first": "Simon",
                    "initial": "S.",
                    "last": "Gubbins"
                },
                {
                    "first": "Margo E.",
                    "initial": "M.E.",
                    "last": "Chase-Topping"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Schley"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Howey"
                },
                {
                    "first": "Paul V.",
                    "initial": "P.V.",
                    "last": "Barnett"
                },
                {
                    "first": "Debi",
                    "initial": "D.",
                    "last": "Gibson"
                },
                {
                    "first": "Nicholas D.",
                    "initial": "N.D.",
                    "last": "Juleff"
                },
                {
                    "first": "Mark E.J.",
                    "initial": "M.E.J.",
                    "last": "Woolhouse"
                }
            ],
            "doi": "10.1126/science.1199884",
            "firstpage": "726",
            "issn": "00368075",
            "lastpage": "729",
            "pmid": "21551063",
            "pub_year": 2011,
            "title": "Relationship between clinical signs and transmission of an infectious disease and the implications for control",
            "volume": "332"
        },
        "b0160": null
    },
    "body_text": [
        {
            "endOffset": 17835,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 17834,
                    "startOffset": 17831
                }
            },
            "secId": "s0005",
            "sentence": "The r1-value is derived by dividing the heterologous neutralisation titre by the homologous neutralisation titre; for the VNT a value equal to or >0.3 suggests that the vaccine virus may impart adequate protection against the heterologous field strain under test [8].",
            "startOffset": 17568,
            "title": "Introduction"
        },
        {
            "endOffset": 35876,
            "parents": [],
            "secId": "s0075",
            "sentence": "Use of the Kruskal-Wallis test to analyse difference between viraemia levels in the control animals and the vaccinated animals is valid given the test does not assume any distribution of data, but the results may not be robust given the small numbers of animals in the control group (two).",
            "startOffset": 35587,
            "title": "Discussion"
        },
        {
            "endOffset": 20499,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The details of some of these isolates have been published previously (13, 14); however, information regarding the provenance of some of the isolates is limited due to the lack of information received from the submitting countries.",
            "startOffset": 20269,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 27220,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Daily viral titres in nasal swabs were used to compute total shedding (i.e. AUC, calculated using the trapezium rule).",
            "startOffset": 27102,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 35130,
            "parents": [],
            "secId": "s0075",
            "sentence": "The varying titres observed between the isolates are consistent with the observation that different serum titres of antibodies against different isolates are observed for a given in vivo potency.",
            "startOffset": 34935,
            "title": "Discussion"
        },
        {
            "endOffset": 36135,
            "parents": [],
            "secId": "s0075",
            "sentence": "There is no superior test to apply to this data, and so future studies using higher animal number to specifically address this observation may be necessary for more robust conclusions about the effect of vaccination on viraemia levels in unprotected animals.",
            "startOffset": 35877,
            "title": "Discussion"
        },
        {
            "endOffset": 27394,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Differences in total shedding between vaccinated animals of different status (i.e. vaccinated-lesions and vaccinated-no lesions) were assessed using Wilcoxon rank-sum tests.",
            "startOffset": 27221,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 16859,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 16858,
                    "startOffset": 16855
                }
            },
            "secId": "s0005",
            "sentence": "Prophylactic/emergency vaccination may also be implemented, and is the main control measure used to control infection in endemic settings [3].",
            "startOffset": 16717,
            "title": "Introduction"
        },
        {
            "endOffset": 17974,
            "parents": [],
            "secId": "s0005",
            "sentence": "Identification of an emergent virus with a poor (<0.3) r1-value against current vaccines may indicate that a new vaccine strain is needed.",
            "startOffset": 17836,
            "title": "Introduction"
        },
        {
            "endOffset": 29276,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "None of these animals had evidence of foot lesions.",
            "startOffset": 29225,
            "title": "Clinical signs"
        },
        {
            "endOffset": 31709,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The AUCs did not differ significantly (p = 0.09) between the \u201cvaccinated with lesions\u201d and \u201cvaccinated without lesions\u201d groups.",
            "startOffset": 31582,
            "title": "Viral shedding from the nose"
        },
        {
            "endOffset": 30453,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The daily concentration of FMDV RNA in the serum is shown in Fig. 3A.",
            "startOffset": 30384,
            "title": "Viraemia"
        },
        {
            "endOffset": 21544,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "A value equal or >0.3 suggests that a high potency vaccine will be protective against the field virus.",
            "startOffset": 21442,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 19878,
            "parents": [],
            "secId": "s0005",
            "sentence": "The objective of this study was to assess the heterologous performance of a multivalent vaccine, incorporating two serotype A components (A-SAU-95 and A-IRN-05), in affording protection of cattle from challenge with a currently circulating field virus of the A/ASIA/G-VII lineage.",
            "startOffset": 19598,
            "title": "Introduction"
        },
        {
            "endOffset": 37710,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 37619,
                    "startOffset": 37615
                },
                "b0160": {
                    "endOffset": 37709,
                    "startOffset": 37705
                }
            },
            "secId": "s0075",
            "sentence": "However, recent field data in a country where this vaccine is used, shows that higher homologous and heterologous titres may be achieved through frequent booster vaccinations [13], in line with previous studies that have investigated this phenomenon experimentally [32].",
            "startOffset": 37440,
            "title": "Discussion"
        },
        {
            "endOffset": 31288,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Pairwise comparison of the groups indicated a significant difference in AUC between the \u201cunvaccinated\u201d and \u201cvaccinated without lesions\u201d groups (Wilcoxon rank-sum test: P = 0.04) and between the \u201cvaccinated with lesions\u201d and \u201cvaccinated without lesions\u201d groups (Wilcoxon rank-sum test: P = 0.002), but not between the \u201cunvaccinated\u201d and \u201cvaccinated with lesions\u201d groups (Wilcoxon rank-sum test: P = 0.06).",
            "startOffset": 30884,
            "title": "Viraemia"
        },
        {
            "endOffset": 27553,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Correlation between total shedding and VNT titres (for each of the three serotype A viruses tested) was assessed used Spearman\u2019s rank correlation coefficient.",
            "startOffset": 27395,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 24199,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Every day thereafter 10 ml of blood, nasal swabs, and rectal temperatures were collected up to and including day 29 (8dpc).",
            "startOffset": 24076,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 26874,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "To compare overall serum levels of FMDV the area under the curve (AUC; i.e. total amount of virus) was calculated by applying the trapezium rule to the time-course of copies/ml in serum for each animal.",
            "startOffset": 26672,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 30883,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "There was a significant difference in AUC amongst groups (Kruskal-Wallis test: P = 0.003).",
            "startOffset": 30793,
            "title": "Viraemia"
        },
        {
            "endOffset": 23336,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Briefly, eighteen castrated male Holstein-Friesian cattle between 6 and 7 months of age (170\u2013230 kg) were brought into the SAPO4/BSL3-Ag high-containment animal facility at TPI and group housed.",
            "startOffset": 23142,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 17567,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 17451,
                    "startOffset": 17446
                },
                "b0030": {
                    "endOffset": 17451,
                    "startOffset": 17446
                },
                "b0035": {
                    "endOffset": 17566,
                    "startOffset": 17563
                }
            },
            "secId": "s0005",
            "sentence": "This is assessed using reference serum which has been raised against individual vaccine antigens [5,6] and used in serological assays such as a 2-dimensional virus neutralisation test (2D-VNT) generating r1-values [7].",
            "startOffset": 17349,
            "title": "Introduction"
        },
        {
            "endOffset": 18629,
            "parents": [],
            "secId": "s0005",
            "sentence": "One PD50 denotes the dose of a vaccine which would protect 50% of vaccinated animals.",
            "startOffset": 18544,
            "title": "Introduction"
        },
        {
            "endOffset": 29404,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "In total, 9 out of the 16 vaccinated animals were protected, equivalent to 56.3% PPG [95% confidence interval (CI): 33.2\u201376.6].",
            "startOffset": 29277,
            "title": "Clinical signs"
        },
        {
            "endOffset": 30373,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "While a positive relationship was also observed for the challenge virus, this was found not to be statistically significant (p = 0.08).",
            "startOffset": 30238,
            "title": "Serology"
        },
        {
            "endOffset": 31581,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "The highest levels of shedding were observed in the unvaccinated animals, with lower levels observed in the vaccinated animals (Fig. 4).",
            "startOffset": 31445,
            "title": "Viral shedding from the nose"
        },
        {
            "endOffset": 32158,
            "parents": [],
            "secId": "s0075",
            "sentence": "The vaccine used in this study is widely used in The Middle East and contains components which have been shown to match FMDV strains likely to be present in these regions.",
            "startOffset": 31987,
            "title": "Discussion"
        },
        {
            "endOffset": 38055,
            "parents": [],
            "secId": "s0075",
            "sentence": "A further monovalent heterologous challenge study may be warranted to confirm the results presented in this study with regard the sole efficacy of the A-SAU-95 component.",
            "startOffset": 37885,
            "title": "Discussion"
        },
        {
            "endOffset": 25681,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Nasal swabs were collected by swabbing the internal surface of both external nares in a circular motion with a single cotton swab.",
            "startOffset": 25551,
            "title": "Nasal swabs"
        },
        {
            "endOffset": 22672,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "This vaccine was chosen because it represents the current vaccine being used in the region where A/ASIA/G-VII outbreaks were seen.",
            "startOffset": 22542,
            "title": "Virus and vaccine"
        },
        {
            "endOffset": 23553,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The remaining two cattle remained unvaccinated.",
            "startOffset": 23506,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 35262,
            "parents": [],
            "refoffsets": {
                "b0145": {
                    "endOffset": 35261,
                    "startOffset": 35254
                },
                "b0150": {
                    "endOffset": 35261,
                    "startOffset": 35254
                }
            },
            "secId": "s0075",
            "sentence": "Previous studies have shown that animals that are clinically protected against homologous challenge do not develop viraemia [29,30].",
            "startOffset": 35130,
            "title": "Discussion"
        },
        {
            "endOffset": 19430,
            "parents": [],
            "secId": "s0005",
            "sentence": "This serotype A lineage emerged from the Indian sub-continent to cause FMD outbreaks in Saudi Arabia, Iran, Turkey, and Armenia.",
            "startOffset": 19302,
            "title": "Introduction"
        },
        {
            "endOffset": 33640,
            "parents": [],
            "secId": "s0075",
            "sentence": "Conversely, the poor correlation of increasing A-IRN-05 antibodies with protection (p = 0.42) supports the observed lack of cross reactivity of these antibodies with the challenge virus in the in vitro vaccine matching studies.",
            "startOffset": 33413,
            "title": "Discussion"
        },
        {
            "endOffset": 26393,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The relationship between VNT and the probability of protection was analysed using generalised linear models with binomial errors and a logit link function.",
            "startOffset": 26238,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 35586,
            "parents": [],
            "secId": "s0075",
            "sentence": "However, the results analysing the AUC showed that vaccination may reduce the total viraemic load over time when compared to non-vaccinated animals, irrespective of whether they were clinically protected or not.",
            "startOffset": 35375,
            "title": "Discussion"
        },
        {
            "endOffset": 21011,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Briefly, the titres were calculated as the antibody dilution required to neutralise 50% of virus/cell mixtures at a virus dose of 100 Tissue Culture Infective Dose 50 (TCID50) and presented as the reciprocal.",
            "startOffset": 20803,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 29570,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Prior to vaccination, no anti-FMDV antibodies were detected by VNT.",
            "startOffset": 29503,
            "title": "Serology"
        },
        {
            "endOffset": 29745,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "On the day of challenge, the two unvaccinated animals remained seronegative, while all vaccinated animals developed titres measured against the individual vaccine components.",
            "startOffset": 29571,
            "title": "Serology"
        },
        {
            "endOffset": 16437,
            "parents": [],
            "secId": "s0005",
            "sentence": "Seven distinct serotypes of FMDV have been described; initially defined in terms of their ability to elicit cross protection after infection, and now described largely in terms of in vitro serological cross reactivity.",
            "startOffset": 16219,
            "title": "Introduction"
        },
        {
            "endOffset": 38209,
            "parents": [],
            "secId": "s0075",
            "sentence": "These results may provide motivation for vaccine manufactures to develop a new vaccine strain with better cross reactivity with the A/ASIA/G-VII lineage.",
            "startOffset": 38056,
            "title": "Discussion"
        },
        {
            "endOffset": 34770,
            "parents": [],
            "refoffsets": {
                "b0135": {
                    "endOffset": 34769,
                    "startOffset": 34762
                },
                "b0140": {
                    "endOffset": 34769,
                    "startOffset": 34762
                }
            },
            "secId": "s0075",
            "sentence": "Attempts to correlate VNT titre with protection and potency have been made, which allow vaccines to be assessed for potency without the need for challenge studies [27,28].",
            "startOffset": 34599,
            "title": "Discussion"
        },
        {
            "endOffset": 34934,
            "parents": [],
            "secId": "s0075",
            "sentence": "The homologous titres for each of the 7 vaccine components observed were of a level that confirmed the high potency nature as reported by the vaccine manufacturer.",
            "startOffset": 34771,
            "title": "Discussion"
        },
        {
            "endOffset": 23505,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "needle).",
            "startOffset": 23497,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 30046,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "As expected, the heterologous titres against the challenge virus (A/IRN/22/2015) were lower than the homologous titres against the two serotype A vaccine viruses.",
            "startOffset": 29884,
            "title": "Serology"
        },
        {
            "endOffset": 33989,
            "parents": [],
            "secId": "s0075",
            "sentence": "Whilst a correlation between increasing titres of antibody to the challenge virus and probability of protection was observed, the lack of statistical significance is most likely due to the low numbers of animals used in the analysis, the overall lower titres of A/IRN22/2015 compared to the homologous A-SAU-95, and inherent variability in the VNT.",
            "startOffset": 33641,
            "title": "Discussion"
        },
        {
            "endOffset": 21181,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The 100 TCID50 was obtained by using five virus doses spanning from 10 to 1000 TCID50; each of these viruses doses were tested against a serial twofold dilution of sera.",
            "startOffset": 21012,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 20171,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0040": {
                    "endOffset": 20077,
                    "startOffset": 20074
                },
                "b0075": {
                    "endOffset": 20170,
                    "startOffset": 20166
                }
            },
            "secId": "s0015",
            "sentence": "Vaccine matching for 10 FMDV field isolates from the A/ASIA/G-VII lineage was elucidated by using a 2D-VNT with IB-RS-2 (renal swine) cells based on the original method [8] and outlined in the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals [15].",
            "startOffset": 19905,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 24763,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The PPG was calculated by dividing the number of vaccinated protected animals by the total number of vaccinated animals.",
            "startOffset": 24643,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 18543,
            "parents": [],
            "secId": "s0005",
            "sentence": "There are two tests described: a protective dose (PD50) test and a protection against podal generalisation (PPG) test.",
            "startOffset": 18425,
            "title": "Introduction"
        },
        {
            "endOffset": 33123,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 33122,
                    "startOffset": 33118
                }
            },
            "secId": "s0075",
            "sentence": "In addition, the OIE manual outlining tests for the fitness of purpose of a routine vaccine suggests a 50% cut off for single dose vaccination, although other authors and the EPP method use a 75% cut off for fitness for purpose of a vaccine, which has been used with great success in South America [25].",
            "startOffset": 32820,
            "title": "Discussion"
        },
        {
            "endOffset": 18134,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 18133,
                    "startOffset": 18130
                }
            },
            "secId": "s0005",
            "sentence": "However, vaccines with a poor r1-value have been shown to afford protection against heterologous challenge if the vaccine is of sufficiently high \u201cpotency\u201d [9].",
            "startOffset": 17974,
            "title": "Introduction"
        },
        {
            "endOffset": 28695,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "All animals displayed ptyalism, nasal discharge, and lip smacking.",
            "startOffset": 28629,
            "title": "Clinical signs"
        },
        {
            "endOffset": 29884,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Fig. 2 compares antibody titres of each animal against the 2 serotype A components of the vaccine and the challenge virus (A/IRN/22/2015).",
            "startOffset": 29746,
            "title": "Serology"
        },
        {
            "endOffset": 37236,
            "parents": [],
            "secId": "s0075",
            "sentence": "The reduction in nasal shedding imparted by the vaccine, even in vaccinated unprotected animals, again suggests that this vaccine may help reduce onward transmission of FMDV even if it does not afford clinical protection.",
            "startOffset": 37015,
            "title": "Discussion"
        },
        {
            "endOffset": 26672,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Only vaccinated animals were included in these analyses.",
            "startOffset": 26616,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 34598,
            "parents": [],
            "secId": "s0075",
            "sentence": "The varying reactivity of the antibodies in all animals at 21 days post vaccination suggest varying antigenic payloads in the vaccine, and is to be expected given formulation has been stated as containing a minimum of 6PD50 not precisely equal to 6PD50.",
            "startOffset": 34345,
            "title": "Discussion"
        },
        {
            "endOffset": 25972,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 25971,
                    "startOffset": 25967
                }
            },
            "secId": "s0035",
            "sentence": "Plaque assays were carried out using a foetal goat tongue cell line (ZZ-R 127)[22].",
            "startOffset": 25889,
            "title": "Nasal swabs"
        },
        {
            "endOffset": 29502,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Table 2 shows the homologous serum titres from all animals at 21 days post vaccination.",
            "startOffset": 29415,
            "title": "Serology"
        },
        {
            "endOffset": 29224,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Three animals were culled at 6dpc on welfare grounds.",
            "startOffset": 29171,
            "title": "Clinical signs"
        },
        {
            "endOffset": 32366,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 32267,
                    "startOffset": 32263
                }
            },
            "secId": "s0075",
            "sentence": "The poor in vitro matching data combined with anecdotal data describing outbreaks in vaccinated animals [13] suggested that the components in this vaccine may be ineffective against the A/ASIA/G-VII lineage.",
            "startOffset": 32159,
            "title": "Discussion"
        },
        {
            "endOffset": 35374,
            "parents": [],
            "secId": "s0075",
            "sentence": "In this study, quantitative real-time RT-PCR was used to show that 14/16 vaccinated animals developed viraemia.",
            "startOffset": 35263,
            "title": "Discussion"
        },
        {
            "endOffset": 26615,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The analysis was carried out separately for each of two vaccine component viruses and for the challenge virus.",
            "startOffset": 26505,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 34344,
            "parents": [],
            "secId": "s0075",
            "sentence": "The vaccine potency was assessed by using pre-existing serological correlates for each of the components with expected potency at the point of market authorisation.",
            "startOffset": 34180,
            "title": "Discussion"
        },
        {
            "endOffset": 21965,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 21913,
                    "startOffset": 21909
                }
            },
            "secId": "s0020",
            "sentence": "This challenge material was a 10% (w/v in M25 PBS) suspension of homogenised tongue lesion collected from Iran and titrated on bovine thyroid (BTY) cells [16] adjusted to a concentration of 2.5 x 105 TCID50/ml.",
            "startOffset": 21755,
            "title": "Virus and vaccine"
        },
        {
            "endOffset": 16716,
            "parents": [],
            "secId": "s0005",
            "sentence": "In FMD free countries, FMD is controlled by restricting animal movements, culling infected animals, and enhancing/implementing farm biosecurity measures.",
            "startOffset": 16563,
            "title": "Introduction"
        },
        {
            "endOffset": 22129,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 22128,
                    "startOffset": 22121
                },
                "b0085": {
                    "endOffset": 22128,
                    "startOffset": 22121
                }
            },
            "secId": "s0020",
            "sentence": "Titration on BTY cells has been shown to be 10x more sensitive than titration on bovine tongues (Bovine Infectious Dose 50 - BID50), and also more ethical [16,17].",
            "startOffset": 21966,
            "title": "Virus and vaccine"
        },
        {
            "endOffset": 21754,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "A virus isolate (A/IRN/22/2015) belonging to the FMDV A/ASIA/G-VII lineage was used to challenge the animals in this study.",
            "startOffset": 21631,
            "title": "Virus and vaccine"
        },
        {
            "endOffset": 17229,
            "parents": [],
            "secId": "s0005",
            "sentence": "The antigen chosen for formulation into a vaccine must be of a suitable potency and have broad antigenic cross reactivity with other isolates.",
            "startOffset": 17087,
            "title": "Introduction"
        },
        {
            "endOffset": 19597,
            "parents": [],
            "secId": "s0005",
            "sentence": "Four isolates of this A/ASIA/G-VII lineage were further antigenically characterised by 2D-VNT at the WRLFMD; the results of which became the provenance of this study.",
            "startOffset": 19431,
            "title": "Introduction"
        },
        {
            "endOffset": 37014,
            "parents": [],
            "refoffsets": {
                "b0155": {
                    "endOffset": 37013,
                    "startOffset": 37009
                }
            },
            "secId": "s0075",
            "sentence": "In addition to viraemia, nasal shedding of FMDV has also been shown to correlate with onward transmission of FMDV from infected animals [31].",
            "startOffset": 36873,
            "title": "Discussion"
        },
        {
            "endOffset": 28628,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "After challenge all animals developed primary lesions at the site of inoculation.",
            "startOffset": 28547,
            "title": "Clinical signs"
        },
        {
            "endOffset": 34179,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 34089,
                    "startOffset": 34085
                }
            },
            "secId": "s0075",
            "sentence": "Each vaccine component was formulated >6PD50 by the vaccine manufacturer (equivalent to >90%PPG [26]), although this experiment did not use homologous challenge to specifically confirm this.",
            "startOffset": 33989,
            "title": "Discussion"
        },
        {
            "endOffset": 31976,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "A similar pattern was seen for the other two viruses tested but this was not statistically significant (p > 0.05).",
            "startOffset": 31862,
            "title": "Viral shedding from the nose"
        },
        {
            "endOffset": 24075,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Sedation was reversed by administering the atipamezole (0.1 mg/kg) via the intravenous route.",
            "startOffset": 23982,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 28909,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0100": {
                    "endOffset": 28908,
                    "startOffset": 28901
                },
                "b0115": {
                    "endOffset": 28801,
                    "startOffset": 28797
                },
                "b0120": {
                    "endOffset": 28908,
                    "startOffset": 28901
                }
            },
            "secId": "s0055",
            "sentence": "Seventeen out of the eighteen cattle had a rectal temperature over 39.5 \u00b0C (Fig. 1) and thus pyrexic [23] but pyrexia was not a reliable predictor of FMD generalisation, in agreement with previous studies [20,24].",
            "startOffset": 28696,
            "title": "Clinical signs"
        },
        {
            "endOffset": 17348,
            "parents": [],
            "secId": "s0005",
            "sentence": "Monitoring antigen cross-reactivity is essential to ensure current vaccines are effective against circulating strains.",
            "startOffset": 17230,
            "title": "Introduction"
        },
        {
            "endOffset": 22878,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "All animal work was undertaken compliant with the Animals (Scientific Procedures) Act 1986, EU Directive 2010/63/EU, and licenced by The Home Office after local ethical review.",
            "startOffset": 22702,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 28312,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Of the remaining 8 vaccine viruses, the highest level of cross reactivity was observed with the A-SAU-95.",
            "startOffset": 28207,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 24998,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Serum samples collected at 0 and 21 days post vaccination were examined for anti-FMDV neutralising antibodies against the vaccine components and the challenge virus A/IRN/22/2015 using the protocol described above for vaccine matching.",
            "startOffset": 24763,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 26215,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Freshly prepared monolayers of cells in 6 well plates were infected with samples, overlaid with indubiose (Sigma) and incubated for 48 h. Virus was inactivated using citric acid, overlay removed, and cells stained using naphthol blue (Sigma).",
            "startOffset": 25973,
            "title": "Nasal swabs"
        },
        {
            "endOffset": 19301,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 19300,
                    "startOffset": 19293
                },
                "b0070": {
                    "endOffset": 19300,
                    "startOffset": 19293
                }
            },
            "secId": "s0005",
            "sentence": "In 2015, samples submitted to the World Reference Laboratory for FMD (WRLFMD) as part of OIE/FAO global surveillance activities detected a new serotype A lineage (A/ASIA/G-VII) [13,14].",
            "startOffset": 19116,
            "title": "Introduction"
        },
        {
            "endOffset": 23894,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Upon ventral recumbency, 0.1 ml of the challenge virus was injected into the intradermal space of the tongue epithelium.",
            "startOffset": 23774,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 31444,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Total virus shed from each animal was calculated by determining the area under each of the daily FMD virus shedding profiles.",
            "startOffset": 31319,
            "title": "Viral shedding from the nose"
        },
        {
            "endOffset": 36402,
            "parents": [],
            "secId": "s0075",
            "sentence": "Moreover, the significant difference in total viraemic load between vaccinated protected and vaccinated unprotected animals, suggests reduced viraemia is either a cause of reduced generalisation or is a result of generalisation \u2013 a relationship yet to be elucidated.",
            "startOffset": 36136,
            "title": "Discussion"
        },
        {
            "endOffset": 22541,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The antigens were double inactivated (BEI), purified, with AI(OH)3 and saponin used as adjuvants.",
            "startOffset": 22444,
            "title": "Virus and vaccine"
        },
        {
            "endOffset": 16108,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 16033,
                    "startOffset": 16030
                },
                "b0010": {
                    "endOffset": 16107,
                    "startOffset": 16104
                }
            },
            "secId": "s0005",
            "sentence": "Foot-and-mouth disease (FMD) is one of the most economically important diseases of livestock, largely due to the direct production losses in endemic areas [1], constraints on international trade, and costs to control the disease [2].",
            "startOffset": 15875,
            "title": "Introduction"
        },
        {
            "endOffset": 20757,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The sera is derived from a high potency vaccine (at least 6PD50) and is a pool of five cattle which has been vaccinated with a monovalent vaccine.",
            "startOffset": 20611,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 21611,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Each r1-value is based on at least two sets of individual results.",
            "startOffset": 21545,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 29170,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The remaining nine vaccinated animals did not develop detectable lameness and were euthanized at the end of the experiment at 8dpc.",
            "startOffset": 29039,
            "title": "Clinical signs"
        },
        {
            "endOffset": 33412,
            "parents": [],
            "secId": "s0075",
            "sentence": "The statistically significant correlation of increasing probability of protection with increasing antibody titres seen when using A-SAU-95 mirrors the r1 value data which supports the idea that only the A-SAU-95 component elicits antibodies which cross neutralise the A/IRN/22/2015 strain.",
            "startOffset": 33123,
            "title": "Discussion"
        },
        {
            "endOffset": 22186,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The inoculum titre was equivalent to 2.5 x 104 BID50/ml.",
            "startOffset": 22130,
            "title": "Virus and vaccine"
        },
        {
            "endOffset": 30237,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "For the vaccine components, there was a significant increase in the probability of protection with increasing VNT for A-SAU-95 (p = 0.03), but not for A-IRN-05 (p = 0.42) as shown in Fig. 2.",
            "startOffset": 30047,
            "title": "Serology"
        },
        {
            "endOffset": 37439,
            "parents": [],
            "secId": "s0075",
            "sentence": "In summary, these data indicate that the multivalent vaccine tested in this study is not appropriate for emergency vaccination use against an incursion of A/ASIA/G-VII into previously FMD free countries.",
            "startOffset": 37236,
            "title": "Discussion"
        },
        {
            "endOffset": 25888,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "This swab was then placed in 2 ml Eagle\u2019s Minimum Essential Medium (EMEM) supplemented with Amphotericin B, Penicillin, Neomycin and Polymixin B, vortexed to elute sample from the swab and stored at \u221280 \u00b0C.",
            "startOffset": 25682,
            "title": "Nasal swabs"
        },
        {
            "endOffset": 24643,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "At the time of culling, irrespective of the day, detailed inspection of the feet was undertaken.",
            "startOffset": 24547,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 21441,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The r1-values are calculated by taking the arithmetic mean of the field virus neutralisation titre and dividing it by the arithmetic mean of the vaccine virus neutralisation titre.",
            "startOffset": 21261,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 21261,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Using linear regression, the expected neutralisation at 100 TCID50 was derived.",
            "startOffset": 21182,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 20802,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The sera was taken 21 days post vaccination.",
            "startOffset": 20758,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 25492,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0105": {
                    "endOffset": 25426,
                    "startOffset": 25422
                }
            },
            "secId": "s0030",
            "sentence": "Viral RNA was quantified on a Mx3005P qPCR System (Agilent technologies, Santa Clara, USA) using an FMDV-specific qRT-PCR assay described previously [21] and a standard curve generated using 10-fold dilutions of an RNA.",
            "startOffset": 25273,
            "title": "Viraemia"
        },
        {
            "endOffset": 28015,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "The serum raised to three vaccine antigens (A-IRN-05, A-Iran-99, and A-Tur-14) showed no cross reactivity with any of the A/ASIA/G-VII isolates.",
            "startOffset": 27871,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 16563,
            "parents": [],
            "secId": "s0005",
            "sentence": "Within each of these serotypes, antigenically distinct viruses can occur that are defined by serological and genetic methods.",
            "startOffset": 16438,
            "title": "Introduction"
        },
        {
            "endOffset": 25272,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "RNA was extracted from serum using a MagMAX\u2122 Express-96 Deep Well Magnetic Particle Processor (Thermal Fisher scientific, Waltham, USA) using the MagMAX\u2122 -96 Viral RNA isolation kit (Thermal Fisher scientific, Waltham, USA) as per the manufacturer\u2019s instructions.",
            "startOffset": 25009,
            "title": "Viraemia"
        },
        {
            "endOffset": 16218,
            "parents": [],
            "secId": "s0005",
            "sentence": "FMD virus (FMDV), the aetiological agent responsible for FMD, is a positive-sense, single stranded RNA virus.",
            "startOffset": 16109,
            "title": "Introduction"
        },
        {
            "endOffset": 24251,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "All animals were examined daily for clinical signs.",
            "startOffset": 24200,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 23981,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "This was repeated 3 more times in different areas of the tongue, a total of 104 BID50.",
            "startOffset": 23895,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 25537,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Viral RNA was quantified in copies/\u00b5l serum.",
            "startOffset": 25493,
            "title": "Viraemia"
        },
        {
            "endOffset": 36643,
            "parents": [],
            "refoffsets": {
                "b0155": {
                    "endOffset": 36642,
                    "startOffset": 36638
                }
            },
            "secId": "s0075",
            "sentence": "It has been shown, however, that levels of viraemia are an important marker associated with onward transmission and so the vaccine may be effective in reducing onward transmission, even in vaccinates which were not clinically affected [31].",
            "startOffset": 36403,
            "title": "Discussion"
        },
        {
            "endOffset": 28530,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Therefore the purpose of this study was to assess whether the current high potency vaccine containing A-SAU-95 components vaccine could protect cattle against heterologous challenge with an A/ASIA/G-VII field isolate.",
            "startOffset": 28313,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 24546,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "On day 29 all animals remaining were culled.",
            "startOffset": 24502,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 28206,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "These poor in vitro matching results, particularly those for A-IRN-05, suggests that current vaccines widely used in Asia may not be effective against viruses from this A/ASIA/G-VII lineage.",
            "startOffset": 28016,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 23773,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Twenty-one days following vaccination (\u201cday 21\u201d or \u201c0 days post challenge\u201d (dpc)), 10ml of blood was collected then all 18 animals were sedated by administering a single intramuscular injection of xylazine (0.22 mg/kg).",
            "startOffset": 23554,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 37884,
            "parents": [],
            "secId": "s0075",
            "sentence": "This study was performed directly in response to the initial reports of the emergence of the A/ASIA/G-VII lineage and utilised vaccine that was being used in field settings.",
            "startOffset": 37711,
            "title": "Discussion"
        },
        {
            "endOffset": 22951,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The PPG test was carried out according to Ph.Eur monograph 01/2015:0063.",
            "startOffset": 22879,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 19001,
            "parents": [],
            "secId": "s0005",
            "sentence": "The PPG test gives the measure of potency in terms of the percentage of animals vaccinated with a single dose that are protected.",
            "startOffset": 18872,
            "title": "Introduction"
        },
        {
            "endOffset": 30792,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "To examine the 3 groups of animals (naive, vaccinated protected, vaccinated unprotected) the area under the curve was calculated to represent total virus in serum over time (Fig. 3B).",
            "startOffset": 30609,
            "title": "Viraemia"
        },
        {
            "endOffset": 20610,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "These isolates were tested against a panel of eleven sera, each raised against a single type A vaccine antigen.",
            "startOffset": 20499,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 22443,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "A high potency (\u22656PD50 per dose) batch of Aftovaxpur\u00ae vaccine containing each of the FMDV components; O1 Manisa, O-3039, O-PanAsia-2, A-IRN-05, A-SAU-95, SAT 2 and Asia-1-Shamir was prepared by Boehringer Ingelheim, Pirbright, United Kingdom, batch # A-415.",
            "startOffset": 22186,
            "title": "Virus and vaccine"
        },
        {
            "endOffset": 32819,
            "parents": [],
            "secId": "s0075",
            "sentence": "The OIE manual and European Pharmacopoeia suggests a 75% cut off for vaccine potency acceptance for those vaccines destined for use in regular vaccination regimens.",
            "startOffset": 32655,
            "title": "Discussion"
        },
        {
            "endOffset": 27102,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "AUCs for the three groups of animals (i.e. unvaccinated, vaccinated-lesions, vaccinated-no lesions) were compared using a Kruskal-Wallis test, followed by pairwise Wilcoxon rank-sum tests to identify differences between groups.",
            "startOffset": 26875,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 18424,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 18265,
                    "startOffset": 18261
                },
                "b0055": {
                    "endOffset": 18334,
                    "startOffset": 18330
                }
            },
            "secId": "s0005",
            "sentence": "This potency is determined by undertaking tests prescribed by both the World Organization for Animal Health (OIE) section 5.3 [10], and the European Pharmacopoeia (Ph.Eur) Monograph 01/2017:0063 [11] and have historically always been carried out with the homologous virus for this purpose.",
            "startOffset": 18135,
            "title": "Introduction"
        },
        {
            "endOffset": 20268,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "These field isolates were tested as part of the WRLFMD remit as an OIE/FAO reference laboratory.",
            "startOffset": 20172,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 17086,
            "parents": [],
            "secId": "s0005",
            "sentence": "Highly concentrated \u201cbanks\u201d of this antigen are maintained by non-endemic countries, allowing rapid vaccine formulation in the event of an outbreak.",
            "startOffset": 16938,
            "title": "Introduction"
        },
        {
            "endOffset": 23142,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0090": {
                    "endOffset": 23041,
                    "startOffset": 23037
                },
                "b0095": {
                    "endOffset": 23141,
                    "startOffset": 23137
                }
            },
            "secId": "s0025",
            "sentence": "The PPG test was chosen as the PD50 test suffers from a low level of reproducibility [18] in contrast to the PPG test which is considered more reliable in ascertaining vaccine efficacy [19].",
            "startOffset": 22952,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 30608,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "Vaccinated animals had lower peak levels of viraemia after challenge.",
            "startOffset": 30539,
            "title": "Viraemia"
        },
        {
            "endOffset": 27870,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "These data revealed poor antigenic match for all ten field viruses against serum raised to the eleven most commonly used FMDV serotype A vaccine antigens in this region, with all r1-values <0.3.",
            "startOffset": 27676,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 16937,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 16936,
                    "startOffset": 16933
                }
            },
            "secId": "s0005",
            "sentence": "Virtually all FMD vaccines comprise chemically inactivated FMDV isolates [4].",
            "startOffset": 16860,
            "title": "Introduction"
        },
        {
            "endOffset": 36872,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 36871,
                    "startOffset": 36867
                }
            },
            "secId": "s0075",
            "sentence": "As stated, whilst the PPG result along with its confidence intervals, is below that which is recommended, the viraemia data suggests this vaccine may reduce viral transmission even in clinically affected vaccinated animals [13].",
            "startOffset": 36644,
            "title": "Discussion"
        },
        {
            "endOffset": 19116,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 19115,
                    "startOffset": 19108
                },
                "b0060": {
                    "endOffset": 19115,
                    "startOffset": 19108
                }
            },
            "secId": "s0005",
            "sentence": "A value of at least 75% is the pass level in the Ph.Eur and also considered epidemiologically appropriate [11,12].",
            "startOffset": 19002,
            "title": "Introduction"
        },
        {
            "endOffset": 18702,
            "parents": [],
            "secId": "s0005",
            "sentence": "The quantity of PD50 doses present in a standard dose is its PD50 value.",
            "startOffset": 18630,
            "title": "Introduction"
        },
        {
            "endOffset": 23496,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Thereafter, 16 animals were each administered 2 ml of the vaccine via the sub-cutaneous route (1.5 in.",
            "startOffset": 23394,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 18871,
            "parents": [],
            "secId": "s0005",
            "sentence": "A PD50 of greater than or equal to 3 is classed as acceptable for routine vaccination, while a PD50 of greater than or equal to 6 is suitable for emergency vaccination.",
            "startOffset": 18703,
            "title": "Introduction"
        },
        {
            "endOffset": 29038,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Both control animals developed vesicular lesions on at least three feet and seven out of sixteen vaccinates on at least one foot.",
            "startOffset": 28909,
            "title": "Clinical signs"
        },
        {
            "endOffset": 30538,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0065",
            "sentence": "The animals with the highest peak levels of viraemia were the unvaccinated controls.",
            "startOffset": 30454,
            "title": "Viraemia"
        },
        {
            "endOffset": 23393,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "On day 0, 10 ml of blood were collected from each animal.",
            "startOffset": 23336,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 27675,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0050",
            "sentence": "Vaccine matching results for field isolates from the A/ASIA/G-VII lineage are shown in Table 1.",
            "startOffset": 27580,
            "title": "Vaccine matching"
        },
        {
            "endOffset": 26504,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The response was status of the animal (i.e. lesions or no lesions) and the explanatory variable was log10 VNT.",
            "startOffset": 26394,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 31861,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Results"
                }
            ],
            "secId": "s0070",
            "sentence": "Total viral shedding was significantly (p = 0.02) negatively correlated (Spearman\u2019s rho = \u22120.54) with virus neutralisation titre against A/IRAN/22/2015.",
            "startOffset": 31709,
            "title": "Viral shedding from the nose"
        },
        {
            "endOffset": 24501,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Animals were culled at the following end-points: (i) the control animals developed lesions on at least three feet; (ii) the vaccinated animals developed lesions on at least one foot (unprotected), or (iii) the animals were culled on welfare grounds.",
            "startOffset": 24252,
            "title": "Vaccine challenge in cattle"
        },
        {
            "endOffset": 32654,
            "parents": [],
            "secId": "s0075",
            "sentence": "The experiment described here demonstrated that a high-potency poorly matched vaccine was able to afford protection against clinical FMD in individual animals, although the PPG value of 56.3% with the lower CI of 33.2% was below that described by both the OIE and European Pharmacopoeia.",
            "startOffset": 32367,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X18301907",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Ryan",
                "initial": "R.",
                "last": "Waters"
            },
            {
                "email": "anna.ludi@pirbright.ac.uk",
                "first": "Anna B.",
                "initial": "A.B.",
                "last": "Ludi"
            },
            {
                "email": null,
                "first": "Veronica L.",
                "initial": "V.L.",
                "last": "Fowler"
            },
            {
                "email": null,
                "first": "Ginette",
                "initial": "G.",
                "last": "Wilsden"
            },
            {
                "email": null,
                "first": "Clare",
                "initial": "C.",
                "last": "Browning"
            },
            {
                "email": null,
                "first": "Simon",
                "initial": "S.",
                "last": "Gubbins"
            },
            {
                "email": null,
                "first": "Bob",
                "initial": "B.",
                "last": "Statham"
            },
            {
                "email": null,
                "first": "Abdelghani",
                "initial": "A.",
                "last": "Bin-Tarif"
            },
            {
                "email": null,
                "first": "Valerie",
                "initial": "V.",
                "last": "Mioulet"
            },
            {
                "email": null,
                "first": "David J.",
                "initial": "D.J.",
                "last": "King"
            },
            {
                "email": null,
                "first": "Claire",
                "initial": "C.",
                "last": "Colenutt"
            },
            {
                "email": null,
                "first": "Emma",
                "initial": "E.",
                "last": "Brown"
            },
            {
                "email": null,
                "first": "Pascal",
                "initial": "P.",
                "last": "Hudelet"
            },
            {
                "email": null,
                "first": "Donald P.",
                "initial": "D.P.",
                "last": "King"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.02.016",
        "firstpage": "1901",
        "issn": "0264410X",
        "keywords": [
            "A/ASIA/G-VII",
            "Challenge",
            "Foot-and-mouth disease virus",
            "Podal generalisation test (PPG)",
            "Vaccine"
        ],
        "lastpage": "1907",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A/ASIA/G-VII lineage"
    }
}